253 related articles for article (PubMed ID: 10051643)
1. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.
Sarkissian CN; Shao Z; Blain F; Peevers R; Su H; Heft R; Chang TM; Scriver CR
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2339-44. PubMed ID: 10051643
[TBL] [Abstract][Full Text] [Related]
2. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
Sarkissian CN; Gámez A
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
[TBL] [Abstract][Full Text] [Related]
3. Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria.
Levy HL; Sarkissian CN; Scriver CR
Mol Genet Metab; 2018 Aug; 124(4):223-229. PubMed ID: 29941359
[TBL] [Abstract][Full Text] [Related]
4. Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria.
Gámez A; Sarkissian CN; Wang L; Kim W; Straub M; Patch MG; Chen L; Striepeke S; Fitzpatrick P; Lemontt JF; O'Neill C; Scriver CR; Stevens RC
Mol Ther; 2005 Jun; 11(6):986-9. PubMed ID: 15922970
[TBL] [Abstract][Full Text] [Related]
5. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria.
Wang L; Gamez A; Sarkissian CN; Straub M; Patch MG; Han GW; Striepeke S; Fitzpatrick P; Scriver CR; Stevens RC
Mol Genet Metab; 2005; 86(1-2):134-40. PubMed ID: 16006165
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria.
Sarkissian CN; Gámez A; Wang L; Charbonneau M; Fitzpatrick P; Lemontt JF; Zhao B; Vellard M; Bell SM; Henschell C; Lambert A; Tsuruda L; Stevens RC; Scriver CR
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20894-9. PubMed ID: 19095795
[TBL] [Abstract][Full Text] [Related]
7. Alternative therapies to address the unmet medical needs of patients with phenylketonuria.
Blau N; Longo N
Expert Opin Pharmacother; 2015 Apr; 16(6):791-800. PubMed ID: 25660215
[TBL] [Abstract][Full Text] [Related]
8. Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.
Burton BK; Longo N; Vockley J; Grange DK; Harding CO; Decker C; Li M; Lau K; Rosen O; Larimore K; Thomas J;
Mol Genet Metab; 2020 Aug; 130(4):239-246. PubMed ID: 32593547
[TBL] [Abstract][Full Text] [Related]
9. Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria.
Jiang Y; Sun B; Qian F; Dong F; Xu C; Zhong W; Huang R; Zhai Q; Jiang Y; Yang S
Sci China Life Sci; 2023 Jan; 66(1):127-136. PubMed ID: 35907113
[TBL] [Abstract][Full Text] [Related]
10. Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.
Bell SM; Wendt DJ; Zhang Y; Taylor TW; Long S; Tsuruda L; Zhao B; Laipis P; Fitzpatrick PA
PLoS One; 2017; 12(3):e0173269. PubMed ID: 28282402
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.
Sarkissian CN; Kang TS; Gámez A; Scriver CR; Stevens RC
Mol Genet Metab; 2011 Nov; 104(3):249-54. PubMed ID: 21803624
[TBL] [Abstract][Full Text] [Related]
12. Study on a novel strategy to treatment of phenylketonuria.
Liu J; Jia X; Zhang J; Xiang H; Hu W; Zhou Y
Artif Cells Blood Substit Immobil Biotechnol; 2002 Jul; 30(4):243-57. PubMed ID: 12227645
[TBL] [Abstract][Full Text] [Related]
13. Phenylketonuria: old disease, new approach to treatment.
Levy HL
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1811-3. PubMed ID: 10051548
[No Abstract] [Full Text] [Related]
14. Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering.
Adolfsen KJ; Callihan I; Monahan CE; Greisen PJ; Spoonamore J; Momin M; Fitch LE; Castillo MJ; Weng L; Renaud L; Weile CJ; Konieczka JH; Mirabella T; Abin-Fuentes A; Lawrence AG; Isabella VM
Nat Commun; 2021 Oct; 12(1):6215. PubMed ID: 34711827
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pah(enu2) mice.
Rossi L; Pierigè F; Carducci C; Gabucci C; Pascucci T; Canonico B; Bell SM; Fitzpatrick PA; Leuzzi V; Magnani M
J Control Release; 2014 Nov; 194():37-44. PubMed ID: 25151978
[TBL] [Abstract][Full Text] [Related]
16. Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).
Goldfinger M; Zeile WL; Corado CR; O'Neill CA; Tsuruda LS; Laipis PJ; Cooper JD
Mol Genet Metab; 2017 Sep; 122(1-2):33-35. PubMed ID: 28506393
[TBL] [Abstract][Full Text] [Related]
17. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
Thomas J; Levy H; Amato S; Vockley J; Zori R; Dimmock D; Harding CO; Bilder DA; Weng HH; Olbertz J; Merilainen M; Jiang J; Larimore K; Gupta S; Gu Z; Northrup H;
Mol Genet Metab; 2018 May; 124(1):27-38. PubMed ID: 29653686
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report.
Safos S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(6):681-92. PubMed ID: 8556141
[TBL] [Abstract][Full Text] [Related]
19. Biochemical analysis of Centaurea depressa phenylalanine ammonia lyase (PAL) for biotechnological applications in phenylketonuria (PKU).
Babaoğlu Aydaş S; Şirin S; Aslim B
Pharm Biol; 2016 Dec; 54(12):2838-2844. PubMed ID: 27246528
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study.
Longo N; Zori R; Wasserstein MP; Vockley J; Burton BK; Decker C; Li M; Lau K; Jiang J; Larimore K; Thomas JA
Orphanet J Rare Dis; 2018 Jul; 13(1):108. PubMed ID: 29973227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
